DLA Piper – The United States Food and Drug Administration (FDA) has released updated cybersecurity guidance titled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions – Guidance for Industry and Food and Drug Administration Staff (Guidance), reflecting the agency’s response to the growing integration of wireless and network connected capabilities in medical devices, which has made cybersecurity controls central to device safety and effectiveness.
Cybersecurity, Privacy, & AI
Trending Now
Your AI Agent Could Become Your Biggest Insider Threat • The New Cyber Deterrent Isn’t a Weapon. It’s Cyber Recovery. • Commerce OIG Calls for Changes to NIST Vulnerability Database Management • Pentagon Looks to AI, Other Tech to Help Tackle Contested Logistics Challenges • How Defensive Cyber Responds to Hockey-Stick Growth of AI-Driven Threats
FDA Issues Revised Cybersecurity Premarket Submission Guidance to Align With Quality Management System Regulation
bangoland | Shutterstock
Stay compliant and protected with daily updates on cybersecurity, data privacy, and federal oversight with our Cyber & Privacy newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.